[go: up one dir, main page]

ATE188692T1 - Fibrinogenrezeptorantagonisten - Google Patents

Fibrinogenrezeptorantagonisten

Info

Publication number
ATE188692T1
ATE188692T1 AT94913969T AT94913969T ATE188692T1 AT E188692 T1 ATE188692 T1 AT E188692T1 AT 94913969 T AT94913969 T AT 94913969T AT 94913969 T AT94913969 T AT 94913969T AT E188692 T1 ATE188692 T1 AT E188692T1
Authority
AT
Austria
Prior art keywords
receptor antagonists
fibrinogen receptor
fibrinogen
image
blood platelets
Prior art date
Application number
AT94913969T
Other languages
English (en)
Inventor
David A Claremon
Nigel Liverton
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE188692T1 publication Critical patent/ATE188692T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT94913969T 1993-04-05 1994-03-29 Fibrinogenrezeptorantagonisten ATE188692T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/042,963 US5441952A (en) 1993-04-05 1993-04-05 Fibrinogen receptor antagonists
PCT/US1994/003400 WO1994022825A1 (en) 1993-04-05 1994-03-29 Fibrinogen receptor antagonists

Publications (1)

Publication Number Publication Date
ATE188692T1 true ATE188692T1 (de) 2000-01-15

Family

ID=21924701

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94913969T ATE188692T1 (de) 1993-04-05 1994-03-29 Fibrinogenrezeptorantagonisten

Country Status (8)

Country Link
US (1) US5441952A (de)
EP (1) EP0693067B1 (de)
JP (1) JPH08508501A (de)
AT (1) ATE188692T1 (de)
AU (1) AU683882B2 (de)
CA (1) CA2159482A1 (de)
DE (1) DE69422615T2 (de)
WO (1) WO1994022825A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017833A1 (en) * 1994-12-09 1996-06-13 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
ATE274499T1 (de) 1995-09-29 2004-09-15 Lilly Co Eli Spiro verbindungen als inhibitoren der fibrinogen-abhängigen blutplättchen aggregation
US6011029A (en) * 1996-02-26 2000-01-04 Bristol-Myers Squibb Company Inhibitors of farnesyl protein transferase
ES2271971T3 (es) * 1996-07-25 2007-04-16 Biogen Idec Ma Inc. Inhibidores de la adhesion celular.
US6686350B1 (en) 1996-07-25 2004-02-03 Biogen, Inc. Cell adhesion inhibitors
US6265418B1 (en) * 1997-07-31 2001-07-24 Ube Industries, Ltd. N-acylamino acid amide compounds and intermediates for preparation thereof
US6623981B2 (en) * 1998-01-27 2003-09-23 Bristol-Myers Squibb Company Detection of patients at risk for developing integrin antagonist/agonist mediated disease states
DE60227185D1 (de) 2001-11-13 2008-07-31 Ortho Mcneil Pharm Inc Substituierte 1,4-benzodiazepine und ihre anwendung in der krebsbehandlung
EP1591120A4 (de) * 2003-01-28 2009-06-10 Takeda Chemical Industries Ltd Rezeptor-agonisten
US9416132B2 (en) 2011-07-21 2016-08-16 Tolero Pharmaceuticals, Inc. Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors
EP3924351B1 (de) 2019-02-12 2025-05-21 Sumitomo Pharma America, Inc. Kristalline form des hydrochlorid salzes von 2-((1r,4r)-4-((3-(3-(trifluoromethyl)phenyl) imidazo[1,2-b]pyridazin-6-yl)amino)cyclohexyl)propan-2-ol

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4313947A (en) * 1974-06-24 1982-02-02 Otsuka Pharmaceutical Co., Ltd. Platelet aggregation inhibiting 2-oxyindoles, their compositions and method of use
DE2549999A1 (de) * 1975-11-07 1977-05-12 Boehringer Mannheim Gmbh Piperidin-derivate und verfahren zu ihrer herstellung
US4064125A (en) * 1976-10-29 1977-12-20 E. R. Squibb And Sons, Inc. Substituted amides having antiinflammatory activity
EP0021592B1 (de) * 1979-05-23 1983-09-28 BEECHAM - WUELFING GmbH & Co. KG Benzolsulfonamid-Derivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Medikamente
DK623586A (da) * 1985-12-27 1987-06-28 Eisai Co Ltd Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne
KR880007441A (ko) * 1986-12-11 1988-08-27 알렌 제이.스피겔 스피로-치환된 글루타르아미드 이뇨제
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
US5039805A (en) * 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
CA2008116C (en) * 1989-02-23 2001-11-20 Thomas Weller Glycine derivatives
NZ234264A (en) * 1989-06-29 1993-05-26 Warner Lambert Co N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives, and pharmaceutical compositions
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
CA2112360A1 (en) * 1991-06-28 1993-12-23 William Edward Bondinell Bicyclic fibrinogen antagonists

Also Published As

Publication number Publication date
EP0693067B1 (de) 2000-01-12
AU683882B2 (en) 1997-11-27
DE69422615D1 (de) 2000-02-17
EP0693067A4 (de) 1995-12-12
EP0693067A1 (de) 1996-01-24
DE69422615T2 (de) 2000-08-03
JPH08508501A (ja) 1996-09-10
US5441952A (en) 1995-08-15
CA2159482A1 (en) 1994-10-13
WO1994022825A1 (en) 1994-10-13
AU6621894A (en) 1994-10-24

Similar Documents

Publication Publication Date Title
ES2112884T3 (es) Antagonistas de receptores de fibrinogeno.
ATE184874T1 (de) Fibrinogen-rezeptor-antagonisten
MX9101310A (es) Antagonistas receptores de fibrinogeno
DE69327536D1 (de) Fibrinogenrezeptor-antagonisten
SE8300736D0 (sv) Novel pharmacologically active compounds
DE69325130D1 (de) N-sulfonyl-2-oxoindol-derivate mit einer affinität für die vasopressin und/oder ocytocin rezeptoren
ATE243694T1 (de) 4-mercaptoacetylamino-(2)benzazepinon(3)- derivate, und verwendung als enkephalinase- inhibitoren
IT8367362A0 (it) Strumento chirurgico per la applicazione di punti e caricatore per questi
FR2624720B1 (fr) Implant pour dispositif d'osteosynthese, notamment du rachis
ATE195737T1 (de) Antagonisten des fibrinogenrezeptors
ATE188692T1 (de) Fibrinogenrezeptorantagonisten
ES2152328T3 (es) Antagonistas del receptor del fibrinogeno.
ES556864A0 (es) Procedimiento para la obtencion de benzopiranos sustituidos.
ES2117654T3 (es) Antagonistas de colecistoquinina.
GR1000664B (el) Παρασκευη ενωσεων αντι-υπερχοληστερολαιμικης τετραζολης και ενδιαμεσων αυτων.
NO930205D0 (no) Benzimidazoler, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
ES2044100T3 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
DK115291D0 (da) Fremgangsmaade til fremstilling af amfotere overfladeaktive imidazolinderivater
SE9003248D0 (sv) Anordning foer att vaenda foeremaal, t ex i samband med avsyning av desamma
EA199700223A1 (ru) Бициклические антагонисты тахикининов, их получение и применение в фармацевтической композиции
IL79835A0 (en) P-acylaminobenzamides
NO305556B1 (no) Tiokarbamoylforbindelser og anvendelse derav samt middel for beskyttelse av tekniske materialer
EP0672413A4 (de) Neue verwendung von (+)-2-nitroxyethyl-apovincaminat.
GB1526382A (en) Transpentenenitrile compounds having antidiarrheal activity
MY106292A (en) (alpha)-adrenergic receptor antagonists.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties